CC
LVGO

Chase Coleman’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Chase Coleman’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250,000
Closed -$7.13M – 77
2020
Q1 		$7.13M Hold
250,000
– – 0.04% 55
2019
Q4 		$6.26M Hold
250,000
– – 0.03% 57
2019
Q3 		$4.36M Buy
+250,000
New +$7.56M 0.02% 63

Other funds holding LVGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
KXA
KPCB XVI Associates Menlo Park, California $225M AUM 26.26% 1-Year Est. Return

Chase Coleman's LVGO Position: Q2 2020 in Review

Chase Coleman sold out of Livongo Health, Inc. Common Stock (LVGO) in Q2 2020, closing a stake of 250,000 shares — an estimated $7.13M sold.

Chase Coleman first reported a position in LVGO in Q3 2019 and held it in 3 quarters. The position peaked at $7.13M in Q1 2020. 291 funds tracked by Wall St. Rank hold LVGO as of Q2 2020.

  • Chase Coleman reported no remaining Livongo Health, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Chase Coleman sold 250,000 Livongo Health, Inc. Common Stock shares in Q2 2020, an estimated $7.13M.
  • Chase Coleman first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Chase Coleman's Livongo Health, Inc. Common Stock position peaked at $7.13M in Q1 2020.
  • 291 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q2 2020.

Based on Tiger Global Management's 13F filing for Q2 2020, filed 14 Aug 2020.